270 related articles for article (PubMed ID: 26641096)
1. AIH: Which Alternative for Difficult-to-Treat Patients?
Sebode M; Schramm C
Dig Dis; 2015; 33 Suppl 2():83-7. PubMed ID: 26641096
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategies for autoimmune hepatitis.
Manns MP; Strassburg CP
Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
Park SW; Um SH; Lee HA; Kim SH; Sim Y; Yim SY; Seo YS; Ryu HS
Clin Mol Hepatol; 2016 Jun; 22(2):281-5. PubMed ID: 27246353
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil as second line therapy in autoimmune hepatitis?
Hennes EM; Oo YH; Schramm C; Denzer U; Buggisch P; Wiegard C; Kanzler S; Schuchmann M; Boecher W; Galle PR; Adams DH; Lohse AW
Am J Gastroenterol; 2008 Dec; 103(12):3063-70. PubMed ID: 18853972
[TBL] [Abstract][Full Text] [Related]
6. Current and novel immunosuppressive therapy for autoimmune hepatitis.
Heneghan MA; McFarlane IG
Hepatology; 2002 Jan; 35(1):7-13. PubMed ID: 11786954
[TBL] [Abstract][Full Text] [Related]
7. Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patients.
Chi XL; Xiao HM; Xie YB; Cai GS; Jiang JM; Tian GJ; Shi MJ; Wu SD; Zhao PT; Chen HJ
BMC Complement Altern Med; 2016 Dec; 16(1):505. PubMed ID: 27923369
[TBL] [Abstract][Full Text] [Related]
8. Therapy of autoimmune hepatitis.
Strassburg CP; Manns MP
Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):673-87. PubMed ID: 22117634
[TBL] [Abstract][Full Text] [Related]
9. Budesonide for the treatment of autoimmune hepatitis.
Snider KR; Potter TG
Ann Pharmacother; 2011 Sep; 45(9):1144-50. PubMed ID: 21878659
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
Than NN; Wiegard C; Weiler-Normann C; Füssel K; Mann J; Hodson J; Hirschfield GM; Lohse AW; Adams DH; Schramm C; Oo YH
Scand J Gastroenterol; 2016 Mar; 51(3):329-36. PubMed ID: 26458216
[TBL] [Abstract][Full Text] [Related]
11. Treatment of autoimmune hepatitis: a review of current and evolving therapies.
Jothimani D; Cramp ME; Mitchell JD; Cross TJ
J Gastroenterol Hepatol; 2011 Apr; 26(4):619-27. PubMed ID: 21073674
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
Efe C; Taii HA; Ytting H; Aehling N; Bhanji RA; Hagström H; Purnak T; Muratori L; Werner M; Muratori P; Klintman D; Schiano TD; Montano-Loza AJ; Berg T; Larsen FS; Alkhouri N; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
Dig Dis Sci; 2018 May; 63(5):1348-1354. PubMed ID: 29569003
[TBL] [Abstract][Full Text] [Related]
13. Treatment Withdrawal in Autoimmune Hepatitis.
Bouma G; van Nieuwkerk CM
Dig Dis; 2015; 33 Suppl 2():88-93. PubMed ID: 26641661
[TBL] [Abstract][Full Text] [Related]
14. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
Woynarowski M; Nemeth A; Baruch Y; Koletzko S; Melter M; Rodeck B; Strassburg CP; Pröls M; Woźniak M; Manns MP;
J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Autoimmune Hepatitis].
Kim JK
Korean J Gastroenterol; 2023 Feb; 81(2):72-85. PubMed ID: 36824035
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil.
Liberal R; Gaspar R; Lopes S; Macedo G
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101487. PubMed ID: 32651078
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
World J Gastroenterol; 2017 Sep; 23(33):6030-6048. PubMed ID: 28970719
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
Richardson PD; James PD; Ryder SD
J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
[TBL] [Abstract][Full Text] [Related]
19. Management of Difficult Cases of Autoimmune Hepatitis.
Lammert C; Loy VM; Oshima K; Gawrieh S
Curr Gastroenterol Rep; 2016 Feb; 18(2):9. PubMed ID: 26780632
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
Fallatah HI; Akbar HO
Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
